Sophie Leducq
2
Documents
Identifiants chercheurs
sophie-leducq- IdRef : 238720330
-
0000-0002-4860-6365
Présentation
Publications
- 1
- 1
- 1
- 1
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
|
|
Efficacy and safety of methotrexate versus placebo as add-on therapy to H1 antihistamines for patients with difficult-to-treat chronic spontaneous urticaria: A randomized, controlled trialJournal of The American Academy of Dermatology, 2020, 82 (1), pp.240-243. ⟨10.1016/j.jaad.2019.07.097⟩
Article dans une revue
hal-02623128v1
|
Evaluation of a low-dose methotrexate added to h1-antihistamines regimen for severe chronic spontaneous urticaria: a phase III, randomized, placebo-controlled trial24. World Congress of dermatology (WCD 2019), Jun 2019, Milan, Italy
Communication dans un congrès
hal-02736447v1
|